ROCHE MOLECULAR SYSTEMS, INC. - BRANCHBURG COBAS® SARS-COV-2 & INFLUENZA A/B; COVID-19 MULTI-ANALYTE RESPIRATORY PANEL NUCLEIC ACID DEVICES
|
Back to Search Results |
|
Catalog Number 09211101190 |
Device Problem
Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/01/2023 |
Event Type
malfunction
|
Event Description
|
In light of the covid-19 pandemic and the subsequent emergency use authorizations (euas) for sars-cov-2 diagnostic tests, the agency has requested heightened reporting beyond the reasonably suggests requirements of 803 to include allegations of false positive or false negative results independent of harm or malfunction or off-label use.Pursuant to the agency¿s instruction, we hereby submit this mdr.A customer from the united states alleged a discrepant result for a single patient while using the cobas® sars-cov-2 & influenza a/b nucleic acid test for use on the cobas liat system.The alleged sample initially generated positive result for influenza a when tested with the cobas influenza a/b & rsv test.The same sample was retested on a separate cobas liat analyzer and using the cobas sars-cov-2 & influenza a/b test which yielded a negative result for influenza a.The results were reported.No harm was alleged.An investigation was conducted to evaluate the customer issue.Per fda¿s eua guidance, 1 mdr will be filed.
|
|
Manufacturer Narrative
|
Instrument data could not be provided from either of the cobas liat analyzers.No assay lot information was provided for review of reagent kits.Without data, a complete investigation could not be performed on the instruments or reagents, however upon further follow up, the customer confirmed that the issue was due to operator error during sample collection.
|
|
Search Alerts/Recalls
|
|
|